Gamma globulin treatment for Kawasaki disease risk factors invalid
Objective To investigate the analysis of gamma globulin therapy Kawasaki disease risk factors. Methods A retrospective analysis of January 2012 January 2013 in our hospital gamma globulin treatment of Kawasaki disease in 400 patients of the clinical data and laboratory results, according to the treatment were divided into gamma globulin treatment effective group 352 cases, gamma globulin therapy group 48 cases. Results Gamma globulin therapy group of patients platelets was 301.7±126.1×109/L, the patient's hemoglobin was 104.2±16.9g/L, albumin 34.1±4.2g/L, significantly lower than the gamma globulin effective treatment group, the difference between the two groups, with statistically significant. Conclusion Kawasaki gamma globulin therapy in high-risk factors include: low platelets, anemia, hypoalbuminemia, etc., the clinical treatment of these children with Kawasaki disease should be given adequate attention, reducing the coronary arteries of children damage.
NETL
NSTL
万方数据
维普
